甲状旁腺机能减退
医学
甲状腺切除术
甲状腺癌
同种异体移植
耐火材料(行星科学)
外科
甲状腺
甲状腺次全切除术
甲状腺全切除术
内科学
移植
物理
天体生物学
作者
Karen Devon,Kathryn Tinckam,Atul Humar,Amin Madani,Jesse D. Pasternak,Bianka Saravana-Bawan,Afshan Zahedi
出处
期刊:Thyroid
[Mary Ann Liebert]
日期:2024-07-18
标识
DOI:10.1089/thy.2024.0115
摘要
Background Hypoparathyroidism following thyroid surgery presents significant challenges, often leading to debilitating symptoms and reduced quality of life despite conventional treatment. We describe a patient who had a staged total thyroidectomy for low-risk thyroid cancer and developed severe refractory iatrogenic hypoparathyroidism in whom we performed the first successful fresh normal-tissue deceased donor parathyroid transplant in an immune-naïve recipient. Methods A rigorous protocol for donor selection and transplantation was developed. Donor criteria aimed at minimizing infectious and immunological risks. Surgical techniques involved retrieval and transplantation of healthy parathyroid glands from a deceased donor into the recipient's muscle tissue, followed by immunosuppression. Results Following transplantation, the patient exhibited rapid resolution of symptoms, normalization of calcium levels, and cessation of calcium supplementation. Follow-up-has revealed sustained graft function without the need for additional therapy. Conclusion Deceased donor parathyroid allotransplantation emerges as a promising therapeutic option for severe refractory hypoparathyroidism, underscoring the potential for physiologic cure and improved quality of life in patients with this debilitating complication of thyroid cancer surgery. Further research is warranted to validate the efficacy and safety of this innovative approach.
科研通智能强力驱动
Strongly Powered by AbleSci AI